Cellectis S.A. (EPA:ALCLS)
3.780
-0.080 (-2.07%)
Jan 12, 2026, 11:43 AM CET
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
€321,270
Profits / Employee
€137,586
Market Cap
279.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 222 | 1 | 0.45% |
| Dec 31, 2023 | 221 | -16 | -6.75% |
| Dec 31, 2022 | 237 | -63 | -21.00% |
| Dec 31, 2021 | 300 | 19 | 6.76% |
| Dec 31, 2020 | 281 | 17 | 6.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| emeis Société anonyme | 83,494 |
| Sanofi | 82,878 |
| Eurofins Scientific SE | 62,696 |
| Clariane SE | 61,798 |
| bioMérieux | 14,754 |
| Sartorius Stedim Biotech | 9,901 |
| Virbac | 6,365 |
Cellectis News
- 6 days ago - Monthly information on share capital and company voting rights - GlobeNewsWire
- 19 days ago - Cellectis (CLLS) Receives New 'Buy' Rating from Clear Street | CLLS Stock News - GuruFocus
- 24 days ago - Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This - Seeking Alpha
- 26 days ago - Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Benzinga
- 26 days ago - Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Benzinga
- 27 days ago - Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis - GlobeNewsWire
- 27 days ago - Cellectis (CLLS) Arbitration Outcome Adjusts License Agreement - GuruFocus
- 27 days ago - Cellectis Announces Arbitral Decision in Dispute with Servier - GlobeNewsWire